sapropterin has been researched along with Parkinson Disease, Secondary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichinose, H; Nagatsu, T | 1 |
| Kang, UJ; Leff, SE; Mandel, RJ; Rendahl, KG; Spratt, SK | 1 |
| Arnold, LA; Blanchet, PJ; Chase, TN; Hyland, K; Konitsiotis, S; Pettigrew, KD | 1 |
1 review(s) available for sapropterin and Parkinson Disease, Secondary
| Article | Year |
|---|---|
GTP cyclohydrolase I gene, tetrahydrobiopterin, and tyrosine hydroxylase gene: their relations to dystonia and parkinsonism.
Topics: Animals; Biopterins; Dopamine; Dystonia; GTP Cyclohydrolase; Haplorhini; Humans; Parkinson Disease; Parkinson Disease, Secondary; Tyrosine 3-Monooxygenase | 1996 |
2 other study(ies) available for sapropterin and Parkinson Disease, Secondary
| Article | Year |
|---|---|
In vivo L-DOPA production by genetically modified primary rat fibroblast or 9L gliosarcoma cell grafts via coexpression of GTPcyclohydrolase I with tyrosine hydroxylase.
Topics: 3T3 Cells; Animals; Antioxidants; Antiparkinson Agents; Apomorphine; Behavior, Animal; Biopterins; Corpus Striatum; Dihydroxyphenylalanine; Disease Models, Animal; Fibroblasts; Gene Expression Regulation, Enzymologic; Genetic Therapy; Gliosarcoma; GTP Cyclohydrolase; Humans; Levodopa; Male; Mice; Microdialysis; Parkinson Disease, Secondary; Rats; Rats, Inbred F344; Recombinant Fusion Proteins; Retroviridae; Transformation, Genetic; Transgenes; Tumor Cells, Cultured; Tyrosine 3-Monooxygenase | 1998 |
Chronic exposure to MPTP as a primate model of progressive parkinsonism: a pilot study with a free radical scavenger.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; Biopterins; Disease Models, Animal; Female; Free Radical Scavengers; Homovanillic Acid; Indans; Macaca fascicularis; Male; Methoxyhydroxyphenylglycol; Motor Activity; Parkinson Disease, Secondary; Pilot Projects; Piperazines | 1998 |